BAX vs. AMN, DVA, EW, RMD, DXCM, STE, PODD, HOLX, MASI, and GMED
Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "medical" sector.
Baxter International vs. Its Competitors
AMN Healthcare Services (NYSE:AMN) and Baxter International (NYSE:BAX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.
Baxter International has a net margin of -1.42% compared to AMN Healthcare Services' net margin of -10.75%. Baxter International's return on equity of 16.96% beat AMN Healthcare Services' return on equity.
AMN Healthcare Services has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.
In the previous week, AMN Healthcare Services had 6 more articles in the media than Baxter International. MarketBeat recorded 12 mentions for AMN Healthcare Services and 6 mentions for Baxter International. Baxter International's average media sentiment score of 0.71 beat AMN Healthcare Services' score of 0.66 indicating that Baxter International is being referred to more favorably in the news media.
99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
AMN Healthcare Services has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.
AMN Healthcare Services currently has a consensus price target of $23.25, suggesting a potential upside of 26.40%. Baxter International has a consensus price target of $30.11, suggesting a potential upside of 31.67%. Given Baxter International's higher probable upside, analysts clearly believe Baxter International is more favorable than AMN Healthcare Services.
Summary
Baxter International beats AMN Healthcare Services on 9 of the 15 factors compared between the two stocks.
Get Baxter International News Delivered to You Automatically
Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Baxter International Competitors List
Related Companies and Tools
This page (NYSE:BAX) was last updated on 9/23/2025 by MarketBeat.com Staff
Free BAX Stock Alerts